Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 20;6(1):166-188.
doi: 10.5334/cpsy.83. eCollection 2022.

What Can Reinforcement Learning Models of Dopamine and Serotonin Tell Us about the Action of Antidepressants?

Affiliations
Review

What Can Reinforcement Learning Models of Dopamine and Serotonin Tell Us about the Action of Antidepressants?

Denis C L Lan et al. Comput Psychiatr. .

Abstract

Although evidence suggests that antidepressants are effective at treating depression, the mechanisms behind antidepressant action remain unclear, especially at the cognitive/computational level. In recent years, reinforcement learning (RL) models have increasingly been used to characterise the roles of neurotransmitters and to probe the computations that might be altered in psychiatric disorders like depression. Hence, RL models might present an opportunity for us to better understand the computational mechanisms underlying antidepressant effects. Moreover, RL models may also help us shed light on how these computations may be implemented in the brain (e.g., in midbrain, striatal, and prefrontal regions) and how these neural mechanisms may be altered in depression and remediated by antidepressant treatments. In this paper, we evaluate the ability of RL models to help us understand the processes underlying antidepressant action. To do this, we review the preclinical literature on the roles of dopamine and serotonin in RL, draw links between these findings and clinical work investigating computations altered in depression, and appraise the evidence linking modification of RL processes to antidepressant function. Overall, while there is no shortage of promising ideas about the computational mechanisms underlying antidepressant effects, there is insufficient evidence directly implicating these mechanisms in the response of depressed patients to antidepressant treatment. Consequently, future studies should investigate these mechanisms in samples of depressed patients and assess whether modifications in RL processes mediate the clinical effect of antidepressant treatments.

Keywords: antidepressants; depression; dopamine; reinforcement learning; serotonin.

PubMed Disclaimer

Conflict of interest statement

MB is supported by the Oxford Health NIHR Biomedical Research Centre and the NIHR Oxford Cognitive Health Clinical Research Facility. The views expressed are those of the authors and not necessarily those of the NIHR. M.B. has received travel expenses from Lundbeck for attending conferences and has acted as a consultant for J&J and CHDR.

Figures

Schematic diagram illustrating the RL framework, showing that the agent receives information about the state they are in and the reward they have received from the environment, and adjusting their action selection policy based on this feedback
Figure 1
Schematic diagram illustrating the RL framework. At every time step, the agent receives information about the state they are in (i.e., a representation of their current environment, such as the speed and position of the car when driving) and the amount of reward they have received. Based on this feedback, the agent aims to adjust its action selection policy to maximise the amount of reward obtained in the future.

References

    1. Aberman, J. E., & Salamone, J. D. (1999). Nucleus accumbens dopamine depletions make rats more sensitive to high ratio requirements but do not impair primary food reinforcement. Neuroscience, 92(2), 545–552. DOI: 10.1016/s0306-4522(99)00004-4 - DOI - PubMed
    1. Admon, R., Kaiser, R. H., Dillon, D. G., Beltzer, M., Goer, F., Olson, D. P., Vitaliano, G., & Pizzagalli, D. A. (2017). Dopaminergic Enhancement of Striatal Response to Reward in Major Depression. The American Journal of Psychiatry, 174(4), 378–386. DOI: 10.1176/appi.ajp.2016.16010111 - DOI - PMC - PubMed
    1. Amlung, M., Marsden, E., Holshausen, K., Morris, V., Patel, H., Vedelago, L., Naish, K. R., Reed, D. D., & McCabe, R. E. (2019). Delay Discounting as a Transdiagnostic Process in Psychiatric Disorders: A Meta-analysis. JAMA Psychiatry, 76(11), 1176–1186. DOI: 10.1001/jamapsychiatry.2019.2102 - DOI - PMC - PubMed
    1. Andrews, P. W., Bharwani, A., Lee, K. R., Fox, M., & Thomson, J. A. (2015). Is serotonin an upper or a downer? The evolution of the serotonergic system and its role in depression and the antidepressant response. Neuroscience and Biobehavioral Reviews, 51, 164–188. DOI: 10.1016/j.neubiorev.2015.01.018 - DOI - PubMed
    1. Artigas, F., Romero, L., de Montigny, C., & Blier, P. (1996). Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Trends in Neurosciences, 19(9), 378–383. DOI: 10.1016/S0166-2236(96)10037-0 - DOI - PubMed

LinkOut - more resources